Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2010

01-04-2010 | Correspondence

Meloxicam as a Cause of Drug-Induced Autoimmune Hepatitis

Authors: Pedro Martínez-Odriozola, Alfonso Gutiérrez-Macías, Joseba Ibarmia-Lahuerta, Josefa Muñóz-Sánchez

Published in: Digestive Diseases and Sciences | Issue 4/2010

Login to get access

Excerpt

Autoimmune hepatitis (AIH) is a chronic necroinflammatory disease of unknown etiology characterized by the presence of circulating autoantibodies, elevated serum gammaglobulins, and histological features of interface hepatitis with lympho-plasmacytic infiltration. In genetically predisposed patients, AIH may be triggered by various environmental factors, including viruses (e.g., measles, hepatitis C, and HSV) and drugs (e.g., minocycline, hydralacine, and statins) [1]. Early diagnosis is of paramount importance because appropriate immunosuppressive therapy usually improves this condition and delays or prevents the development of hepatic complications or the need for liver transplantation [2]. We describe here a patient in whom meloxicam probably triggered the development of AIH. …
Literature
4.
5.
go back to reference Pérez-Aguilar F, Berenguer M, Ramírez-Palanca JJ, et al. Chronic autoimmune hepatitis following cholestatic hepatitis caused by droxicam. Med Clin (Barc). 1996;106:460–462. Pérez-Aguilar F, Berenguer M, Ramírez-Palanca JJ, et al. Chronic autoimmune hepatitis following cholestatic hepatitis caused by droxicam. Med Clin (Barc). 1996;106:460–462.
Metadata
Title
Meloxicam as a Cause of Drug-Induced Autoimmune Hepatitis
Authors
Pedro Martínez-Odriozola
Alfonso Gutiérrez-Macías
Joseba Ibarmia-Lahuerta
Josefa Muñóz-Sánchez
Publication date
01-04-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0805-5

Other articles of this Issue 4/2010

Digestive Diseases and Sciences 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.